$1.51 Billion is the total value of First Light Asset Management, LLC's 77 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 47.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPNE | Buy | SEASPINE HOLDINGS CORP | $94,417,000 | +1.1% | 5,426,241 | +1.4% | 6.26% | -9.4% |
| HALO | Sell | HALOZYME THERAPEUTICS INC | $83,853,000 | -23.7% | 2,011,350 | -21.8% | 5.56% | -31.6% |
| CDNA | Sell | CAREDX INC | $82,571,000 | -36.2% | 1,212,677 | -32.2% | 5.48% | -42.9% |
| PRTA | Buy | PROTHENA CORPORATION PLC | $73,745,000 | +198.6% | 2,935,707 | +42.8% | 4.89% | +167.7% |
| MODN | Buy | MODEL N INC | $68,690,000 | +47.0% | 1,949,762 | +48.8% | 4.55% | +31.7% |
| ATRC | Buy | ATRICURE INC | $54,251,000 | +20.4% | 828,002 | +2.3% | 3.60% | +7.9% |
| AXGN | Buy | AXOGEN INC | $51,813,000 | +35.3% | 2,557,412 | +19.6% | 3.44% | +21.2% |
| OMCL | Sell | OMNICELL INC | $49,230,000 | -6.8% | 379,075 | -13.9% | 3.26% | -16.5% |
| NEO | Buy | NEOGENOMICS INC | $48,385,000 | +73.8% | 1,003,216 | +94.0% | 3.21% | +55.7% |
| STRO | Buy | SUTRO BIOPHARMA INC | $46,850,000 | +160.9% | 2,058,447 | +148.9% | 3.11% | +133.9% |
| HCAT | Buy | HEALTH CATALYST INC | $46,639,000 | +10.2% | 997,201 | +2.6% | 3.09% | -1.2% |
| TNDM | Buy | TANDEM DIABETES CARE INC | $46,343,000 | +81.2% | 525,129 | +96.5% | 3.07% | +62.4% |
| GKOS | Sell | GLAUKOS CORPORATION | $44,706,000 | -12.4% | 532,657 | -21.5% | 2.96% | -21.5% |
| XENT | Buy | INTERSECT ENT INC | $42,525,000 | +51.8% | 2,036,645 | +66.5% | 2.82% | +36.1% |
| TEVA | Buy | TEVA PHARMACEUTICAL IND | $42,399,000 | +29.6% | 3,674,104 | +8.3% | 2.81% | +16.1% |
| KRYS | Sell | KRYSTAL BIOTECH INC | $37,866,000 | +28.3% | 491,511 | -0.0% | 2.51% | +15.0% |
| CUTR | New | CUTERA INC | $37,386,000 | – | 1,244,117 | +100.0% | 2.48% | – |
| ARWR | Sell | ARROWHEAD PHARMACEUTICALS INC | $35,598,000 | -34.1% | 536,836 | -23.8% | 2.36% | -41.0% |
| INSM | Sell | INSMED INC | $32,389,000 | -9.2% | 950,953 | -11.2% | 2.15% | -18.6% |
| ALDX | New | ALDEYRA THERAPEUTICS INC | $31,173,000 | – | 2,624,001 | +100.0% | 2.07% | – |
| KRTX | Buy | KARUNA THERAPEUTICS INC | $31,079,000 | +122.7% | 258,500 | +88.1% | 2.06% | +99.5% |
| OPRX | Sell | OPTIMIZERX CORP | $28,967,000 | +35.6% | 594,199 | -13.3% | 1.92% | +21.5% |
| YMAB | Buy | Y-MABS THERAPEUTICS INC | $28,554,000 | -9.3% | 944,253 | +48.5% | 1.89% | -18.7% |
| RARE | Buy | ULTRAGENYX PHARMACEUTICAL INC | $24,760,000 | -16.4% | 217,459 | +1.7% | 1.64% | -25.0% |
| GMAB | Buy | GENMAB AS | $24,204,000 | -6.6% | 737,261 | +15.7% | 1.60% | -16.2% |
| ARNA | Buy | ARENA PHARMACEUTICALS INC | $24,028,000 | -2.9% | 346,274 | +7.5% | 1.59% | -13.0% |
| SIBN | Buy | SI-BONE INC | $22,322,000 | +10.8% | 701,732 | +4.1% | 1.48% | -0.7% |
| MEIP | Buy | MEI PHARMA INC | $21,880,000 | +118.5% | 6,378,935 | +68.2% | 1.45% | +95.8% |
| KRMD | Sell | REPRO-MED SYSTEMS INC | $19,308,000 | -45.4% | 5,485,238 | -6.6% | 1.28% | -51.1% |
| Buy | APTOSE BIOSCIENCES INC | $18,539,000 | +404.3% | 3,102,788 | +269.7% | 1.23% | +351.8% | |
| TCRR | New | TCR2 THERAPEUTICS INC | $18,249,000 | – | 826,474 | +100.0% | 1.21% | – |
| MRVI | Buy | MARAVAI LIFE SCIENCES | $17,501,000 | +69.5% | 491,049 | +33.4% | 1.16% | +51.8% |
| AXNX | New | AXONICS MODULATION TECHNOLOGIES | $16,861,000 | – | 281,528 | +100.0% | 1.12% | – |
| CDXS | Sell | CODEXIS INC | $16,119,000 | -23.3% | 704,186 | -26.8% | 1.07% | -31.3% |
| BTAI | Buy | BIOXCEL THERAPEUTICS INC | $15,470,000 | +255.5% | 358,439 | +280.5% | 1.03% | +218.6% |
| STIM | New | NEURONETICS INC | $14,223,000 | – | 1,149,777 | +100.0% | 0.94% | – |
| QDEL | Buy | QUIDEL CORP | $14,094,000 | +21.3% | 110,170 | +70.3% | 0.93% | +8.6% |
| ATEC | Buy | ALPHATEC HOLDINGS INC | $11,953,000 | +521.3% | 756,989 | +471.3% | 0.79% | +458.5% |
| KIDS | Sell | ORTHOPEDIATRICS CORP | $11,088,000 | -4.2% | 227,450 | -18.9% | 0.74% | -14.1% |
| JYNT | Buy | THE JOINT CORP | $10,549,000 | +107.0% | 218,085 | +12.4% | 0.70% | +85.4% |
| NVTA | New | INVITAE CORPORATION | $9,646,000 | – | 252,442 | +100.0% | 0.64% | – |
| ITMR | New | ITAMAR MEDICAL LTD | $8,981,000 | – | 375,000 | +100.0% | 0.60% | – |
| JAZZ | Buy | JAZZ PHARMACEUTICALS PLC | $8,791,000 | +2.5% | 53,484 | +2.9% | 0.58% | -8.0% |
| New | AKUMIN INC | $7,379,000 | – | 1,994,200 | +100.0% | 0.49% | – | |
| TPTX | Buy | TURNING POINT THERAPEUTICS | $5,569,000 | -17.9% | 58,879 | +5.7% | 0.37% | -26.5% |
| SLP | Buy | SIMULATIONS PLUS INC | $4,685,000 | -9.2% | 74,080 | +3.3% | 0.31% | -18.6% |
| ZYME | Sell | ZYMEWORKS INC | $3,722,000 | -60.2% | 117,848 | -40.4% | 0.25% | -64.3% |
| LHCG | Buy | LHC GROUP INC | $2,964,000 | -5.3% | 15,500 | +5.6% | 0.20% | -15.1% |
| SIEN | New | SIENTRA INC | $2,187,000 | – | 300,000 | +100.0% | 0.14% | – |
| QTRX | New | QUANTERIX CORPORATION | $1,585,000 | – | 27,100 | +100.0% | 0.10% | – |
| MASS | Sell | 908 DEVICES INC | $1,004,000 | -78.0% | 20,700 | -74.1% | 0.07% | -80.1% |
| ABBV | ABBVIE | $647,000 | +0.9% | 5,981 | 0.0% | 0.04% | -8.5% | |
| ITGR | New | INTEGER HOLDINGS CORPORATION | $538,000 | – | 5,846 | +100.0% | 0.04% | – |
| NUVA | Buy | NUVASIVE INC | $515,000 | +75.2% | 7,850 | +50.2% | 0.03% | +54.5% |
| BAX | Buy | BAXTER INTERNATIONAL INC | $500,000 | +91.6% | 5,929 | +82.0% | 0.03% | +73.7% |
| NVST | Buy | ENVISTA HOLDINGS CORP | $481,000 | +58.7% | 11,793 | +31.3% | 0.03% | +45.5% |
| HRC | Buy | HILL-ROM HOLDINGS INC | $480,000 | +130.8% | 4,346 | +104.9% | 0.03% | +113.3% |
| CI | Buy | CIGNA CORPORATION | $470,000 | +44.6% | 1,943 | +24.6% | 0.03% | +29.2% |
| GSK | New | GLAXOSMITHKLINE PLC | $449,000 | – | 12,574 | +100.0% | 0.03% | – |
| BMY | New | BRISTOL MYERS SQUIBB CO | $458,000 | – | 7,256 | +100.0% | 0.03% | – |
| ANTM | ANTHEM INC COM | $447,000 | +12.0% | 1,244 | 0.0% | 0.03% | 0.0% | |
| SYNH | Buy | SYNEOS HEALTH INC CLASS A | $435,000 | +43.1% | 5,736 | +28.4% | 0.03% | +31.8% |
| HOLX | Buy | HOLOGIC INC | $435,000 | +79.0% | 5,845 | +75.0% | 0.03% | +61.1% |
| GILD | Buy | GILEAD SCIENCES INC | $433,000 | +43.9% | 6,705 | +29.6% | 0.03% | +31.8% |
| WAT | New | WATERS CORPORATION | $436,000 | – | 1,536 | +100.0% | 0.03% | – |
| AVTR | New | AVANTOR INC | $422,000 | – | 14,596 | +100.0% | 0.03% | – |
| CVS | Buy | CVS HEALTH CORPORATION | $415,000 | +45.1% | 5,519 | +32.0% | 0.03% | +33.3% |
| ICUI | Buy | ICU MEDICAL INC | $419,000 | +87.9% | 2,039 | +95.9% | 0.03% | +75.0% |
| BDX | BECTON DICKINSON AND CO | $404,000 | -2.9% | 1,662 | 0.0% | 0.03% | -12.9% | |
| UTHR | New | UNITED THERAPEUTICS CORP DEL | $412,000 | – | 2,466 | +100.0% | 0.03% | – |
| EBS | New | EMERGENT BIOSOLUTIONS INC | $399,000 | – | 4,294 | +100.0% | 0.03% | – |
| PRGO | Buy | PERRIGO COMPANY | $398,000 | +68.6% | 9,823 | +86.2% | 0.03% | +52.9% |
| JNJ | JOHNSON & JOHNSON | $355,000 | +4.4% | 2,161 | 0.0% | 0.02% | -4.0% | |
| SNY | SANOFI-SYNTHELABO | $329,000 | +1.9% | 6,650 | 0.0% | 0.02% | -8.3% | |
| PFE | PFIZER INC | $307,000 | -1.6% | 8,469 | 0.0% | 0.02% | -13.0% | |
| UHS | New | UNIVERSAL HEALTH SERVICES, INC CLASS B | $273,000 | – | 2,050 | +100.0% | 0.02% | – |
| MCK | New | MCKESSON CORP | $263,000 | – | 1,346 | +100.0% | 0.02% | – |
| GRFS | Exit | GRIFOLS S A | $0 | – | -10,166 | -100.0% | -0.01% | – |
| AMGN | Exit | AMGEN INC | $0 | – | -1,092 | -100.0% | -0.02% | – |
| A | Exit | AGILENT TECHNOLOGIES INC | $0 | – | -2,548 | -100.0% | -0.02% | – |
| BIO | Exit | BIO RAD LABS INC | $0 | – | -548 | -100.0% | -0.02% | – |
| NVS | Exit | NOVARTIS AG | $0 | – | -3,535 | -100.0% | -0.02% | – |
| MRK | Exit | MERCK & CO. INC | $0 | – | -4,247 | -100.0% | -0.03% | – |
| UNH | Exit | UNITEDHEALTH GROUP INC | $0 | – | -1,543 | -100.0% | -0.04% | – |
| ALXN | Exit | ALEXION PHARMACEUTICALS INC | $0 | – | -6,200 | -100.0% | -0.07% | – |
| XLV | Exit | SELECT SECTOR SPDR TRetf | $0 | – | -18,241 | -100.0% | -0.15% | – |
| IHI | Exit | ISHARES TRetf | $0 | – | -7,580 | -100.0% | -0.18% | – |
| IBB | Exit | ISHARES TRetf | $0 | – | -16,713 | -100.0% | -0.19% | – |
| PSCH | Exit | INVESCO EXCH TRADED FD TR IIetf | $0 | – | -17,285 | -100.0% | -0.22% | – |
| VAPO | Exit | VAPOTHERM INC | $0 | – | -189,862 | -100.0% | -0.38% | – |
| IONS | Exit | IONIS PHARMACEUTICALS INC | $0 | – | -179,601 | -100.0% | -0.75% | – |
| FPRX | Exit | FIVE PRIME THERAPEUTICS INC | $0 | – | -1,563,618 | -100.0% | -1.97% | – |
| OXFD | Exit | OXFORD IMMUNOTEC GLOBAL PLC | $0 | – | -4,946,629 | -100.0% | -6.39% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-17
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ATRICURE INC | 40 | Q3 2023 | 9.7% |
| NEOGENOMICS INC | 40 | Q3 2023 | 10.6% |
| SANOFI-SYNTHELABO | 40 | Q3 2023 | 1.9% |
| JOHNSON & JOHNSON | 40 | Q3 2023 | 0.3% |
| PFIZER INC | 39 | Q2 2023 | 0.9% |
| BIOMARIN PHARMACEUTICAL INC | 36 | Q3 2023 | 1.6% |
| OMNICELL INC | 33 | Q3 2023 | 7.7% |
| QUIDEL CORP | 33 | Q4 2021 | 3.7% |
| NOVARTIS AG-SPONSORED ADR | 33 | Q3 2023 | 0.4% |
| MODEL N INC | 30 | Q3 2023 | 9.0% |
View First Light Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| REATA PHARMACEUTICALS INC | May 15, 2023 | 1,290,193 | 3.9% |
| Axogen, Inc. | February 03, 2023 | 1,942,270 | 4.6% |
| MODEL N, INC. | February 03, 2023 | 1,845,134 | 4.9% |
| MEI Pharma, Inc.Sold out | May 31, 2022 | 0 | 0.0% |
| PROTHENA CORP PUBLIC LTD CO | March 01, 2022 | 1,805,038 | 3.9% |
| Intersect ENT, Inc. | February 14, 2022 | 1,375,210 | 4.1% |
| SeaSpine Holdings Corp | February 14, 2022 | 6,847,707 | 18.8% |
| Oxford Immunotec Global PLCSold out | February 10, 2021 | 0 | 0.0% |
| ENDOLOGIX INC /DE/ | February 14, 2020 | 816,236 | 4.6% |
| Nuvectra CorpSold out | February 14, 2020 | 0 | 0.0% |
View First Light Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-09 |
| 4 | 2024-04-08 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
View First Light Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.